• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

PatientsLikeMe

edit

PatientsLikeMe is the leading online community for people with life-changing conditions. Patients embrace the open sharing of personal health data because they believe that information can change the course of their disease.

PatientsLikeMe is committed to providing a better, more effective way to capture valuable results and share them with patients, healthcare professionals, and industry organizations that are trying to treat the disease.

Recent Milestones

edit

• 
  PatientsLikeMe received $2M in Venture Round funding. (8/8/12)
  Posted 8/8/12 at 6:51pm via masshightech.com
• 
  PatientsLikeMe — published a study in the journal Nature Biotechnology arguing that lithium carbonate does not slow the progression of ALS, also known as Lou Gehrig’s disease (4/25/11)
  Posted 4/26/11 at 3:42am via masshightech.com
• 
  PatientsLikeMe received $10M in Venture Round funding. (8/19/10)
  Posted 8/20/10 at 2:38pm via masshightech.com
• 
  PatientsLikeMe received $5M in Series A funding. (2/5/07)
  Posted 5/3/08 at 12:45pm via patientslikeme.com
• 
  PatientsLikeMe added Benjamin Heywood as President.
  Posted 5/3/08 at 12:45pm
• 
  PatientsLikeMe added Jeff Cole as CTO.
  Posted 5/3/08 at 12:45pm
• 
  PatientsLikeMe added James Heywood as Chairman.
  Posted 5/3/08 at 12:45pm
• 
  PatientsLikeMe added David S. Williams III as Head of Business Development & Marketing.
  Posted 5/3/08 at 12:45pm
• 
  PatientsLikeMe added Paul Wicks as R&D Director.
  Posted 5/19/10 at 12:52pm

Videos

Screenshots

edit

Above: PatientsLikeMe Screenshot -- #1
Uploaded: 6/10/09

Traffic Analytics

Quantcast

Compete

Sources

1. patientslikeme.com [edit]
2. PatientsLikeMe take in $8M funding (masshightech.com) [edit]
3. PatientsLikeMe takes in $2M in equity (masshightech.com) [edit]
PatientsLikeMe uses social network for ALS study (masshightech.com) [edit]